Ovid Application Error
Toxicity study of a new camptothecin anti-cancer agent CKD-602 in dogs: 4-Week continuous intravenous dose by infusion pump and 4-week repeated intravenous dose.
Han, S. C. a; Kim, D. G. a; Han, E. H. b; Kim, Y. B. a; Hwang, I. C. c; Kim, C. Y. a,*
Regulatory Toxicology and Pharmacology.
58(2):275-284, November 2010.
(Format: HTML, PDF)